Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
CBSN
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose - a fifth of the dose of its current COVID-19 vaccine, Spikevax - by refining its immune target.
The approval "adds an important new tool to help protect people at high risk of severe disease from COVID-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday.

As the Trump administration continues to prepare military options for strikes in Iran, U.S. allies in the Mideast, including Turkey, Oman and Qatar, are attempting to head off that possibility by brokering diplomatic talks, multiple regional officials told CBS News. Camilla Schick and Eleanor Watson contributed to this report.

Another winter storm may be headed toward the East Coast of the United States this weekend, on the heels of a powerful and deadly system that blanketed huge swaths of the country in snow and ice. The effects of that original storm have lingered for many areas in its path, and will likely remain as repeated bouts of Arctic air plunge downward from Canada and drive temperatures below freezing. Nikki Nolan contributed to this report. In:











